The Institute of Cancer Research (ICR) and the Royal Marsden NHS foundation trust in London have announced a joint five-year research strategy to target targeting non-cancerous cells within tumors — a strategy that could open up new frontiers in the fight against cancer.
“We are aiming to tilt the balance in favor of the immune system and make the environment inhospitable to cancer cells and favorable for elements of the immune system that can attack them, so that we can make the disease extinct within the body,” said Kevin Harrington, professor of biological cancer therapeutics at the ICR and consultant at the Royal Marsden.
>Read the entire article at this link: Scientists reveal new lines of attack to raise cancer survival rate
